US launches trade investigation into Germany over drug pricing

?The U.S. has launched a trade investigation ?into a German plan to ?lower ?its spending on pharmaceutical products, to see whether it is unreasonable or discriminatory, U.S. Trade Representative Jamieson Greer said on Thursday. The probe comes ?under Section 301 of the Trade Act of 1974, Greer said, adding that his office will open a docket for submission of written comments on June 25 and its Section 301 Committee will hold ?a public hearing on the probe in September. “I am particularly concerned with news that ?Germany is fast-tracking legislation that would further reduce its spending on innovative pharmaceuticals,” Greer…